GRAL — GRAIL, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1699031 ·
Last close
$140.58
Market Cap
$6.28B
52W High
$166.48
52W Low
$41.50
ADV30
1,275,126
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 44,687,000 | -12,566,000 | -148,360,000 | -110,247,000 | 2,843,686,000 | 55,645,000 | 301,032,000 |
| Mar 2026 | 40,785,000 | -14,307,000 | -135,765,000 | -93,187,000 | 2,803,474,000 | 69,344,000 | 302,788,000 |
| Dec 2025 | 43,597,000 | -11,136,000 | -124,411,000 | -99,176,000 | 2,922,015,000 | 249,727,000 | 344,153,000 |
| Sep 2025 | 36,194,000 | -13,733,000 | -125,291,000 | -88,977,000 | 2,601,031,000 | 126,892,000 | 361,068,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-294,749,000
Investing CF
$-310,043,000
Financing CF
$423,321,000
CapEx
$-1,413,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-9.75
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,415,115,000
Inventory
$17,763,000
Receivables
$19,757,000
ST Investments
$805,964,000
EBIT TTM
$-533,827,000
Pretax Income TTM
$-529,467,000
Interest Exp TTM
—
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$165,263,008
EBITDA
$-378,488,992
Free Cash Flow
$-103,579,128
Enterprise Value
$2,634,607,104
Total Cash
$861,609,024
Total Debt
$91,309,000
Shares Out
44,666,234
Trailing EPS
$-9.69
Book Value
$56.93
ROE
-16.1%
ROA
-12.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 147,172,000 | -534,163,000 | -408,351,000 | 2,922,015,000 | 344,153,000 | 2,577,862,000 | -299,007,000 |
| Dec 2024 | 125,595,000 | -768,222,000 | -2,027,005,000 | 2,983,307,000 | 479,902,000 | 2,503,405,000 | -577,156,000 |
| Dec 2023 | 93,105,000 | -796,916,000 | -1,465,685,000 | 3,913,814,000 | 267,627,000 | 0 | -595,800,000 |
| Dec 2022 | 55,550,000 | -742,459,000 | -5,399,098,000 | 4,937,986,000 | 291,825,000 | 0 | -561,313,000 |
TTM Snapshot
Revenues TTM
$156,120,000
NetIncome TTM
$-395,325,000
OpCashFlow TTM
—
Assets (Latest)
$2,803,474,000
Forward EPS
$-8.94
Max Pain — expiry 2026-10-16
max pain strike: $90.00 · spot: $140.58 · call oi: 11,679 · put oi: 6,529
Expected Move to 2026-10-16:
±$12.20
(8.68%) —
implied range
$128.38 –
$152.78
· ATM straddle on $140.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CHE | CHEMED CORP | $6.53B | $499.82 | — |
| PACS | PACS Group, Inc. | $6.86B | $43.30 | — |
| HIMS | Hims & Hers Health, Inc. | $6.96B | $30.92 | — |
| RDNT | RadNet, Inc. | $5.58B | $70.91 | — |
| SHC | Sotera Health Co | $5.15B | $18.06 | — |
News headlines (Yahoo Finance, 1h cache)
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
2026-10-05 20:01 · Yahoo
Why GRAIL (GRAL) Is Up 12.9% After Positive FDA Panel Verdict On Galleri Trial Results
2026-10-03 06:07 · Yahoo
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
2026-09-30 17:35 · Yahoo
GRAIL (GRAL) Wins FDA Panel Backing, Is It Now Overvalued?
2026-09-24 20:17 · Yahoo
GRAIL Stock Jumped 34% Yesterday. The FDA Just Told Its Investors Why.
2026-09-22 06:07 · Yahoo
GRAL Stock Clocks Best Day In Over 1.5 Years — FDA Papers Lift Galleri Approval Hopes
2026-09-21 20:50 · Yahoo
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
2026-10-09 15:38 · Yahoo
2 Growth Stocks to Buy in October
2026-10-08 20:15 · Yahoo
Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)
2026-10-04 23:20 · Yahoo
Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years?
2026-10-04 14:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.